123 related articles for article (PubMed ID: 37216358)
1. Discovery of novel PARP-1 inhibitors using tandem
Bhatnagar A; Nath V; Kumar N; Kumar V
J Biomol Struct Dyn; 2024 Apr; 42(7):3396-3409. PubMed ID: 37216358
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
3. Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors.
Zhou Y; Tang S; Chen T; Niu MM
Molecules; 2019 Nov; 24(23):. PubMed ID: 31766720
[TBL] [Abstract][Full Text] [Related]
4. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
Halder AK; Saha A; Saha KD; Jha T
J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
[TBL] [Abstract][Full Text] [Related]
5. Structure based pharmacophore study to identify possible natural selective PARP-1 trapper as anti-cancer agent.
Kumar C; P T V L; Arunachalam A
Comput Biol Chem; 2019 Jun; 80():314-323. PubMed ID: 31078910
[TBL] [Abstract][Full Text] [Related]
6. Pharmacophore based virtual screening for identification of effective inhibitors to combat HPV 16 E6 driven cervical cancer.
Mohan A; Krishnamoorthy S; Sabanayagam R; Schwenk G; Feng E; Ji HF; Muthusami S
Eur J Pharmacol; 2023 Oct; 957():175961. PubMed ID: 37549730
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the mechanistic roles of chlorine substituted phthalazinone-based compounds containing chlorophenyl moiety towards the differential inhibition of poly (ADP-ribose) polymerase-1 in the treatment of lung cancer.
Okunlola FO; Olotu FA; Soliman MES
J Biomol Struct Dyn; 2022; 40(21):10878-10886. PubMed ID: 34463214
[TBL] [Abstract][Full Text] [Related]
8. Novel PARP-1 Inhibitor Scaffolds Disclosed by a Dynamic Structure-Based Pharmacophore Approach.
Baptista SJ; Silva MM; Moroni E; Meli M; Colombo G; Dinis TC; Salvador JA
PLoS One; 2017; 12(1):e0170846. PubMed ID: 28122037
[TBL] [Abstract][Full Text] [Related]
9. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
10. Leveraging shape screening and molecular dynamics simulations to optimize PARP1-Specific chemo/radio-potentiators for antitumor drug design.
Khizer H; Maryam A; Ansari A; Ahmad MS; Khalid RR
Arch Biochem Biophys; 2024 Jun; 756():110010. PubMed ID: 38642632
[TBL] [Abstract][Full Text] [Related]
11. Active site fingerprinting and pharmacophore screening strategies for the identification of dual inhibitors of protein kinase C (ΡΚCβ) and poly (ADP-ribose) polymerase-1 (PARP-1).
Chadha N; Silakari O
Mol Divers; 2016 Aug; 20(3):747-61. PubMed ID: 27216445
[TBL] [Abstract][Full Text] [Related]
12. In-silico method for elucidation of prodigiosin as PARP-1 inhibitor a prime target of Triple-negative breast cancer.
Sundararajan P; Dharmaraj Rajaselvi D; Vivekananthan S; Priya Ramasamy S
Bioorg Chem; 2023 Sep; 138():106618. PubMed ID: 37244231
[TBL] [Abstract][Full Text] [Related]
13. AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists.
Kang KM; Lee I; Nam H; Kim YC
Eur J Med Chem; 2022 Oct; 240():114556. PubMed ID: 35849939
[TBL] [Abstract][Full Text] [Related]
14. In Silico Discovery of Novel Flavonoids as Poly ADP Ribose Polymerase (PARP) Inhibitors.
Shah A; Parmar G; Seth AK
Curr Comput Aided Drug Des; 2021; 17(3):344-350. PubMed ID: 32268868
[TBL] [Abstract][Full Text] [Related]
15. Integrated support vector machine and pharmacophore based virtual screening driven identification of thiophene carboxamide scaffold containing compound as potential PARP1 inhibitor.
Singh M; Rajawat J; Kuldeep J; Shukla N; Mishra DP; Siddiqi MI
J Biomol Struct Dyn; 2022 Nov; 40(18):8494-8507. PubMed ID: 33950778
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Novel Apigenin-Piperazine Hybrids as Potent and Selective Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors for the Treatment of Cancer.
Long H; Hu X; Wang B; Wang Q; Wang R; Liu S; Xiong F; Jiang Z; Zhang XQ; Ye WC; Wang H
J Med Chem; 2021 Aug; 64(16):12089-12108. PubMed ID: 34404206
[TBL] [Abstract][Full Text] [Related]
17. In silico investigation of PARP-1 catalytic domains in holo and apo states for the design of high-affinity PARP-1 inhibitors.
Salmas RE; Unlu A; Yurtsever M; Noskov SY; Durdagi S
J Enzyme Inhib Med Chem; 2016; 31(1):112-20. PubMed ID: 26083304
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanisms of PARP-1 Inhibitor 7-Methylguanine.
Nilov D; Maluchenko N; Kurgina T; Pushkarev S; Lys A; Kutuzov M; Gerasimova N; Feofanov A; Švedas V; Lavrik O; Studitsky VM
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32245127
[TBL] [Abstract][Full Text] [Related]
19. Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors.
Chadha N; Jaggi AS; Silakari O
Mol Divers; 2017 Aug; 21(3):655-660. PubMed ID: 28653128
[TBL] [Abstract][Full Text] [Related]
20. Modeling of the Enzyme-Substrate Complexes of Human Poly(ADP-Ribose) Polymerase 1.
Nilov DK; Pushkarev SV; Gushchina IV; Manasaryan GA; Kirsanov KI; Švedas VK
Biochemistry (Mosc); 2020 Jan; 85(1):99-107. PubMed ID: 32079521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]